Basic HTML Version
Lesion & patient
characteristics
Patients = 131/
lesions = 136
Age (yrs)
65.8 ±11
Men
107
82 %
Smoking
38
29 %
Diabetes mellitus
58 44 %
Hypertension
92 70 %
Acute coronary syndrome
77
59 %
Prior angioplasty
63
48 %
B2/C type lesions
62
48 %
Total stent length
per lesion (mm)
14.6 ± 3.7
Mean stent diameter (mm)
2.3 ± 0.2
Small vessel subgroup analysis
131 patients/136 lesions
Small vessel subgroup outcomes at 6- & 12-month FU
Definition small vessel: PRO-Kinetic stents 2.0, 2.25, 2.5mm used, clinical and QCA analysis completed
for all patients, 6- and 12-month data available for all 131 patients.
MACE is composed of any death, any myocardial infarction (Q and non Q MI),or any percutaneous or
surgical target vessel revascularisation (TVR) or target lesion revascularisation (TLR)
Source: Prof. Ran Kornowski, oral presentation, ICI 2009
37 %
7.6
6.1
4.6
0.0
MACE
3.1
Death
MI
CABG
TVR
TLR
ST
[%]
16
12
8
4
0
12.2
3.1
1.5 1.5
9.2
7.6
0.0
6mo results
12mo results
1.5 1.5